Mingming Lv
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Genetics top 10%
- Mesenchymal stem cell research
Papers in
-
- Cancer-related molecular mechanisms research 12
- MicroRNA in disease regulation 3
- Breast Cancer Treatment Studies 2
- Cancer, Hypoxia, and Metabolism 1
-
- Pregnancy and preeclampsia studies 4
- Co-authors
- Yayi Hou (6 shared papers)Cheng Lu (7 shared papers)Tingting Wang (6 shared papers)Sunan Shen (3 shared papers)Yujun Xu (3 shared papers)Fengliang Wang (5 shared papers)Ruijing Tang (2 shared papers)Nan Lan Xu (2 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (3 papers)Tumor Biology (2 papers)Life Sciences (2 papers)Frontiers in Oncology (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Mingming Lv
30 papers receiving 845 citations
Peers
Comparison fields: 5 of 58
- Cancer Research 406
- Genetics 67
- Obstetrics and Gynecology 66
- Oncology 81
- Immunology 58
Countries citing papers authored by Mingming Lv
This map shows the geographic impact of Mingming Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingming Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingming Lv more than expected).
Fields of papers citing papers by Mingming Lv
This network shows the impact of papers produced by Mingming Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingming Lv. The network helps show where Mingming Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingming Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 104 | |
| 2 | 2016 | 84 | |
| 3 | 2015 | 67 | |
| 4 | 2016 | 63 | |
| 5 | 2019 | 60 | |
| 6 | 2015 | 59 | |
| 7 | 2012 | 48 | |
| 8 | 2011 | 37 | |
| 9 | 2014 | 35 | |
| 10 | 2019 | 30 | |
| 11 | 2020 | 30 | |
| 12 | 2017 | 27 | |
| 13 | 2023 | 27 | |
| 14 | 2015 | 26 | |
| 15 | 2020 | 23 | |
| 16 | 2016 | 21 | |
| 17 | 2024 | 20 | |
| 18 | 2018 | 17 | |
| 19 | 2021 | 13 | |
| 20 | 2012 | 10 |
About Mingming Lv
Mingming Lv is a scholar working on Cancer Research, Obstetrics and Gynecology, Genetics, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 858 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (12 papers), Pregnancy and preeclampsia studies (4 papers), MicroRNA in disease regulation (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), Mesenchymal stem cell research (2 papers), Pleural and Pulmonary Diseases (2 papers), Breast Cancer Treatment Studies (2 papers) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Cancer Research (406 citations), Genetics (67 citations), Obstetrics and Gynecology (66 citations), Oncology (81 citations) and Immunology (58 citations). Mingming Lv has collaborated with scholars based in China and United States. Frequent co-authors include Yayi Hou, Cheng Lu, Tingting Wang, Sunan Shen, Yujun Xu, Fengliang Wang, Ruijing Tang, Nan Lan Xu, Pengfei Xu and Jing Ren. Their work appears in journals such as Biomedicine & Pharmacotherapy, Tumor Biology, Life Sciences, Frontiers in Oncology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.